Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Sionna Therapeutics, Inc. (SION) had Weighted-Average Shares Outstanding (Basic) of 39.96M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-75.27M |
|
-- |
|
-- |
|
$88.98M |
|
$-88.98M |
|
$13.71M |
|
$-75.27M |
|
$-75.27M |
|
$-75.27M |
|
$-75.27M |
|
$-75.27M |
|
$-75.27M |
|
$-88.98M |
|
$-91.39M |
|
|
Weighted-Average Shares Outstanding (Basic) |
39.96M |
39.96M |
|
$-1.88 |
|
$-1.88 |
|
| Balance Sheet Financials | |
$241.42M |
|
$2.23M |
|
$84.53M |
|
$325.95M |
|
$11.71M |
|
-- |
|
$7.41M |
|
$19.12M |
|
$306.83M |
|
$306.83M |
|
$306.83M |
|
44.72M |
|
| Cash Flow Statement Financials | |
$-66.30M |
|
$-118.75M |
|
$205.71M |
|
$38.75M |
|
$59.41M |
|
$20.66M |
|
$12.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-66.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.53% |
|
-24.53% |
|
-23.09% |
|
-24.53% |
|
$6.86 |
|
$-1.67 |
|
$-1.66 |
|